Health
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate – Investing.com
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate
By Michael Erman
(Reuters) – The United States government will pay Johnson & Johnson (N:JNJ) over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. That compares with the $19.50 per …
-
General16 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General17 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General16 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News21 hours agoBrisbane rising on global rankings, but still behind southern capitals